These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

602 related items for PubMed ID: 20722047

  • 21. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
    Ji SY, Zeng FQ, Guo Q, Tan GZ, Tang HF, Luo YJ, Tang ZQ, Han YF.
    Chin Med J (Engl); 2010 Mar 05; 123(5):517-22. PubMed ID: 20367973
    [Abstract] [Full Text] [Related]

  • 22. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
    Kameda H, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Tokuhira M, Amano K, Takeuchi T.
    J Rheumatol; 2005 Sep 05; 32(9):1719-26. PubMed ID: 16142867
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review.
    Qushmaq KA, Chalmers A, Esdaile JM.
    J Rheumatol; 2000 Dec 05; 27(12):2855-9. PubMed ID: 11128676
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Immunosuppressant treatment in refractory myositis. Our experience].
    Danieli MG, Spalletta C, Moretti R, Calabrese V, Marchetti A, Gabrielli A, Logullo F.
    Recenti Prog Med; 2009 Oct 05; 100(10):451-7. PubMed ID: 20030167
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Rituximab as therapy for refractory polymyositis and dermatomyositis.
    Noss EH, Hausner-Sypek DL, Weinblatt ME.
    J Rheumatol; 2006 May 05; 33(5):1021-6. PubMed ID: 16541475
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis.
    Saito E, Koike T, Hashimoto H, Miyasaka N, Ikeda Y, Hara M, Yamada H, Yoshida T, Harigai M, Ichikawa Y.
    Mod Rheumatol; 2008 May 05; 18(1):34-44. PubMed ID: 18217197
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Dermatomyositis and polymyositis: clinical aspects and treatment].
    Hachulla E.
    Ann Med Interne (Paris); 2001 Nov 05; 152(7):455-64. PubMed ID: 11965087
    [Abstract] [Full Text] [Related]

  • 37. Features of polymyositis and dermatomyositis in the elderly: a case-control study.
    Pautas E, Chérin P, Piette JC, Pelletier S, Wechsler B, Cabane J, Herson S.
    Clin Exp Rheumatol; 2000 Nov 05; 18(2):241-4. PubMed ID: 10812498
    [Abstract] [Full Text] [Related]

  • 38. Clinical efficacy of intravenous immunoglobulins for the treatment of dermatomyositis skin lesions without muscle disease.
    Bounfour T, Bouaziz JD, Bézier M, Cordoliani F, Saussine A, Petit A, Juillard C, Bagot M, Rybojad M.
    J Eur Acad Dermatol Venereol; 2014 Sep 05; 28(9):1150-7. PubMed ID: 23906502
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Relationship between the onset and outcome of interstitial pneumonia associated with polymyositis and dermatomyositis].
    Saku N, Ohno S, Sugiyama Y, Kitamura S.
    Nihon Kokyuki Gakkai Zasshi; 1998 Jul 05; 36(7):585-9. PubMed ID: 9805908
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.